Lifestyle predictors for inconsistent participation to fecal based colorectal cancer screening.
Adult
Alcohol Drinking
/ psychology
Body Mass Index
Colorectal Neoplasms
/ prevention & control
Diet
/ psychology
Early Detection of Cancer
/ psychology
Exercise
/ psychology
Female
Healthy Lifestyle
Humans
Life Style
Logistic Models
Male
Occult Blood
Odds Ratio
Patient Acceptance of Health Care
/ statistics & numerical data
Program Evaluation
Risk Factors
Smoking
/ psychology
Surveys and Questionnaires
Journal
BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800
Informations de publication
Date de publication:
15 Feb 2022
15 Feb 2022
Historique:
received:
10
11
2021
accepted:
03
02
2022
entrez:
16
2
2022
pubmed:
17
2
2022
medline:
11
3
2022
Statut:
epublish
Résumé
Consistent participation in colorectal cancer (CRC) screening with repeated fecal immunochemical test (FIT) is important for the success of the screening program. We investigated whether lifestyle risk factors for CRC were related to inconsistent participation in up to four rounds of FIT-screening. We included data from 3,051 individuals who participated in up to four FIT-screening rounds and returned a lifestyle questionnaire. Using logistic regression analyses, we estimated associations between smoking habits, body mass index (BMI), physical activity, alcohol consumption, diet and a healthy lifestyle score (from least favorable 0 to most favorable 5), and inconsistent participation (i.e. not participating in all rounds of eligible FIT screening invitations). Altogether 721 (24%) individuals were categorized as inconsistent participants Current smoking and BMI ≥30 kg/m Lifestyle behaviors were associated with inconsistent participation in FIT-screening. Initiatives aimed at increasing participation rates among those with the unhealthiest lifestyle have a potential to improve the efficiency of screening.
Sections du résumé
BACKGROUND
BACKGROUND
Consistent participation in colorectal cancer (CRC) screening with repeated fecal immunochemical test (FIT) is important for the success of the screening program. We investigated whether lifestyle risk factors for CRC were related to inconsistent participation in up to four rounds of FIT-screening.
METHOD
METHODS
We included data from 3,051 individuals who participated in up to four FIT-screening rounds and returned a lifestyle questionnaire. Using logistic regression analyses, we estimated associations between smoking habits, body mass index (BMI), physical activity, alcohol consumption, diet and a healthy lifestyle score (from least favorable 0 to most favorable 5), and inconsistent participation (i.e. not participating in all rounds of eligible FIT screening invitations).
RESULTS
RESULTS
Altogether 721 (24%) individuals were categorized as inconsistent participants Current smoking and BMI ≥30 kg/m
CONCLUSIONS
CONCLUSIONS
Lifestyle behaviors were associated with inconsistent participation in FIT-screening. Initiatives aimed at increasing participation rates among those with the unhealthiest lifestyle have a potential to improve the efficiency of screening.
Identifiants
pubmed: 35168592
doi: 10.1186/s12885-022-09287-9
pii: 10.1186/s12885-022-09287-9
pmc: PMC8848967
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
172Subventions
Organisme : Helse Sør-Øst RHF
ID : 2019070
Informations de copyright
© 2022. The Author(s).
Références
Cancer Treat Rev. 2017 Mar;54:87-98
pubmed: 28236723
Eur J Public Health. 2007 Apr;17(2):125-33
pubmed: 16751631
PLoS One. 2017 Jun 16;12(6):e0179864
pubmed: 28622365
Gut. 2015 Feb;64(2):282-91
pubmed: 24812001
Prev Med. 2018 Jan;106:185-193
pubmed: 29109015
J Med Screen. 2008;15(3):137-42
pubmed: 18927096
Br J Cancer. 2018 Jul;119(2):251-257
pubmed: 29991698
Clin Gastroenterol Hepatol. 2012 Jun;10(6):633-8
pubmed: 22426085
Eur J Public Health. 2021 Apr 24;31(2):346-355
pubmed: 33313657
Clin Gastroenterol Hepatol. 2014 Oct;12(10):1624-34.e1
pubmed: 24534546
Am J Gastroenterol. 2012 Oct;107(10):1570-8
pubmed: 22850431
Colorectal Dis. 2014 Jan;16(1):28-32
pubmed: 24034143
J Med Screen. 2021 Jun;28(2):114-121
pubmed: 32295488
World J Gastroenterol. 2016 Jul 21;22(27):6276-86
pubmed: 27468217
Asian Pac J Cancer Prev. 2012;13(12):5989-94
pubmed: 23464391
Br J Cancer. 2015 Apr 28;112(9):1562-7
pubmed: 25742470
Gastroenterology. 2021 Mar;160(4):1085-1096.e5
pubmed: 33227280
Gut. 2018 Feb;67(2):291-298
pubmed: 27733426
Eur J Public Health. 2016 Feb;26(1):158-68
pubmed: 26370437
BMC Cancer. 2017 Aug 7;17(1):524
pubmed: 28784093
CA Cancer J Clin. 2018 Jan;68(1):31-54
pubmed: 29160902
Eur J Public Health. 2021 Oct 11;31(4):890-894
pubmed: 34347069
Dis Colon Rectum. 2018 Apr;61(4):417-418
pubmed: 29521819
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
Endoscopy. 2020 Aug;52(8):687-700
pubmed: 32572858
Bol Oficina Sanit Panam. 1968 Oct;65(4):281-393
pubmed: 4234760
Br J Cancer. 2017 Aug 8;117(4):461-469
pubmed: 28704841
Br J Cancer. 2017 Jan 3;116(1):44-49
pubmed: 27923037
Cancer Prev Res (Phila). 2012 Feb;5(2):164-78
pubmed: 22084361
Am J Clin Nutr. 1998 Aug;68(2):266-74
pubmed: 9701182
Lancet. 2014 Apr 26;383(9927):1490-1502
pubmed: 24225001
BMC Gastroenterol. 2006 Jan 13;6:5
pubmed: 16412216
Int J Colorectal Dis. 2017 Aug;32(8):1117-1124
pubmed: 28501944
Psychol Med. 2014 Jul;44(10):2231-40
pubmed: 24274839
Int J Cancer. 2012 Feb 1;130(3):622-30
pubmed: 21412763
Endoscopy. 2017 Nov;49(11):1075-1086
pubmed: 28938500